Valuation : Jerusalem Pharmaceuticals Co. Ltd.

Market Cap 128M 110M 103M 94.36M 176M 12.09B 177M 1.23B 474M 6.19B 480M 469M 19.72B P/E 2024
13.7x
P/E 2025 8.13x
Enterprise Value 117M 101M 94.56M 86.32M 161M 11.06B 162M 1.12B 433M 5.66B 439M 429M 18.03B EV / Sales 2024
1.47x
EV / Sales 2025 1.47x
Free-Float
35.74%
Yield 2024
2.09%
Yield 2025 3.26%
1 day-1.11%
1 month-0.56%
3 months-4.05%
6 months+52.69%
Current year+54.35%
1 week 3.55
Extreme 3.55
3.59
1 month 3.5
Extreme 3.5
3.66
Current year 2.28
Extreme 2.285
4
1 year 1.9
Extreme 1.9
4
3 years 1.74
Extreme 1.745
4
5 years 1.32
Extreme 1.325
4
10 years 0.8
Extreme 0.795
4
Manager TitleAgeSince
Chief Executive Officer - 2013-06-30
Director of Finance/CFO - 2020-02-29
Chief Tech/Sci/R&D Officer - 1988-12-31
Director TitleAgeSince
Chairman 91 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%0.00%+71.08%+86.35% 128M
-0.21%-1.30%+18.91%+65.89% 48.26B
-2.49%-3.62%+42.16%+110.97% 40.5B
+0.72%-2.00%-10.20%+11.00% 11.85B
+3.29%-2.86%+14.11%+81.79% 11.83B
-1.50%-1.50%+24.76%+142.59% 9.36B
-0.86%-3.20%+22.45%+38.38% 7.5B
-1.23%-1.57%+39.31%-13.47% 7.37B
+0.60%-2.51%+19.49%+209.21% 7.28B
-0.32%-2.67%-46.31%+18.10% 5.19B
Average -0.31%-2.06%+19.58%+75.08% 14.93B
Weighted average by Cap. -0.61%-1.84%+21.89%+79.88%

Financials

2024 2025
Net sales 39.82M 34.25M 32.21M 29.4M 54.99M 3.77B 55.17M 382M 148M 1.93B 150M 146M 6.14B 48.95M 42.09M 39.59M 36.14M 67.59M 4.63B 67.81M 469M 181M 2.37B 184M 180M 7.55B
Net income 5.04M 4.33M 4.07M 3.72M 6.96M 476M 6.98M 48.32M 18.68M 244M 18.92M 18.51M 777M 10.18M 8.76M 8.24M 7.52M 14.06M 963M 14.11M 97.66M 37.75M 493M 38.24M 37.41M 1.57B
Net Debt -10.32M -8.88M -8.35M -7.62M -14.25M -976M -14.3M -98.99M -38.26M -500M -38.76M -37.92M -1.59B -10.9M -9.37M -8.81M -8.05M -15.05M -1.03B -15.1M -105M -40.4M -528M -40.92M -40.03M -1.68B
Logo Jerusalem Pharmaceuticals Co. Ltd.
Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.
Employees
595
Date Price Change Volume
26-09-02 US$3.550 -1.11% 900
26-09-01 US$3.590 +1.13% 100
26-08-31 US$3.550 0.00% 100
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!